Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Measuring self-efficacy in people with multiple sclerosis: a validation study

C E Schwartz1, L Coulthard-Morris, Q Zeng

  • 1Frontier Science and Technology Research Foundation, Inc., Brookline, MA 02146, USA.

Archives of Physical Medicine and Rehabilitation
|April 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DNA methylation epi-signature is associated with two molecularly and phenotypically distinct clinical subtypes of Phelan-McDermid syndrome.

Clinical epigenetics·2021
Same author

Probing lepton flavour violation via neutrinoless [Formula: see text] decays with the ATLAS detector.

The European physical journal. C, Particles and fields·2017
Same author

A new method to distinguish hadronically decaying boosted <i>Z</i> bosons from <i>W</i> bosons using the ATLAS detector.

The European physical journal. C, Particles and fields·2017
Same author

Search for supersymmetry at [Formula: see text] TeV in final states with jets and two same-sign leptons or three leptons with the ATLAS detector.

The European physical journal. C, Particles and fields·2017
Same author

Measurement of the differential cross-sections of prompt and non-prompt production of [Formula: see text] and [Formula: see text] in <i>pp</i> collisions at [Formula: see text] and 8 TeV with the ATLAS detector.

The European physical journal. C, Particles and fields·2017
Same author

Measurement of the transverse momentum and [Formula: see text] distributions of Drell-Yan lepton pairs in proton-proton collisions at [Formula: see text] TeV with the ATLAS detector.

The European physical journal. C, Particles and fields·2017

The MS Self-Efficacy Scale (MSSE) demonstrates strong reliability and validity for assessing self-efficacy in individuals with multiple sclerosis (MS). This validated tool is suitable for use in the MS population.

Area of Science:

  • Psychometric validation
  • Multiple Sclerosis (MS) research
  • Self-efficacy measurement

Background:

  • Self-efficacy is crucial for managing chronic conditions like multiple sclerosis (MS).
  • Accurate measurement of self-efficacy in MS patients is essential for effective interventions.
  • Existing measures may require psychometric evaluation for the MS population.

Purpose of the Study:

  • To evaluate the psychometric properties of the MS Self-Efficacy Scale (MSSE).
  • To determine the reliability and validity of the MSSE in individuals with multiple sclerosis.

Main Methods:

  • Cross-sectional study design with mail-based data collection and retesting.
  • Participants included 141 individuals with MS from a large hospital registry, covering a wide disability spectrum.

Related Experiment Videos

  • Assessed using the MS Self-Efficacy Scale (MSSE), Expanded Disability Status Scale, Sickness Impact Profile, and Ryff Happiness Scale.
  • Main Results:

    • The MSSE exhibited high internal consistency and test-retest reliability for both the overall scale and its subscales (SE Function, SE Control).
    • Convergent and divergent validity analyses indicated that the MSSE is sensitive and specific.
    • These findings support the psychometric soundness of the MSSE.

    Conclusions:

    • The MS Self-Efficacy Scale (MSSE) is a psychometrically sound instrument.
    • MSSE is appropriate for assessing self-efficacy in the multiple sclerosis (MS) population.
    • The scale's reliability and validity support its use in clinical and research settings for MS.